Loading clinical trials...
Loading clinical trials...
Evaluation of the Use of Transvaginal Resorbable Biologic Mesh as Compared to Traditional Non-Mesh Surgical Repair for Treating Pelvic Floor Disorders
Conditions
Interventions
MatriStem Pelvic Floor Matrix
native tissue repair
Locations
13
United States
Stanford School of Medicine
Stanford, California, United States
Cleveland Clinic FLorida
Weston, Florida, United States
Female Pelvic Medicine & Urogynecology
Grand Rapids, Michigan, United States
Premier Urology Group
Edison, New Jersey, United States
Atlantic Health System
Morristown, New Jersey, United States
Princeton Urogynecology
Princeton, New Jersey, United States
Start Date
June 11, 2014
Primary Completion Date
April 28, 2021
Completion Date
April 28, 2021
Last Updated
February 8, 2022
NCT04829058
NCT05602246
NCT07150442
NCT06461234
NCT06802497
NCT05042453
Lead Sponsor
Integra LifeSciences Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions